ePrints

A phase Ib dose-escalation study of GSK2256098 (FAKi) plus trametinib (MEKi) in patients with selected advanced solid tumors

Lookup NU author(s): Professor Ruth Plummer, Professor Alastair GreystokeORCiD

Downloads

Full text for this publication is not currently held within this repository. Alternative links are provided below where available.

Publication metadata

Author(s): Arkenau HT, Gazzah A, Plummer R, Blagden SP, Mak G, Soria JC, Greystoke A, Rizzuto I, Rogan D, Mazumdar J, Laubscher K, Auger KR, Swartz LS, Mattern ML, Nebot N, Singh RP, Fleming RA, Yan L

Publication type: Conference Proceedings (inc. Abstract)

Publication status: Published

Conference Name: American Society of Clinical Oncology (ASCO) 2015 Annual Meeting

Year of Conference: 2015

Print publication date: 20/05/2015

Acceptance date: 01/01/1900

ISSN: 0732-183X

Publisher: American Society of Clinical Oncology

Series Title: Journal of Clinical Oncology

Share